25 XP   0   0   10

Jilin Jian Yisheng Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Jilin Jian Yisheng Pharmaceutical Co Ltd together

PenkeI guess you are interested in Jilin Jian Yisheng Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jilin Jian Yisheng Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jilin Jian Yisheng Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jilin Jian Yisheng Pharmaceutical Co Ltd.

Quick analysis of Jilin Jian Yisheng Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Jilin Jian Yisheng Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.80
Expected worth in 1 year
¥7.41
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.91
Return On Investment
13.0%

For what price can you sell your share?

Current Price per Share
¥6.95
Expected price per share
¥5.2 - ¥7.75
How sure are you?
50%

1. Valuation of Jilin Jian Yisheng Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥6.95

Intrinsic Value Per Share

¥-2.29 - ¥3.59

Total Value Per Share

¥4.51 - ¥10.38

2. Growth of Jilin Jian Yisheng Pharmaceutical Co Ltd (5 min.)




Is Jilin Jian Yisheng Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$310.4m$303.3m$7m2.3%

How much money is Jilin Jian Yisheng Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$11.4m$13.2m-$1.7m-15.6%
Net Profit Margin10.0%10.9%--

How much money comes from the company's main activities?

3. Financial Health of Jilin Jian Yisheng Pharmaceutical Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#175 / 1010

Most Revenue
#92 / 1010

Most Profit
#91 / 1010

Most Efficient
#110 / 1010

What can you expect buying and holding a share of Jilin Jian Yisheng Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Jilin Jian Yisheng Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Jilin Jian Yisheng Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Jilin Jian Yisheng Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Jilin Jian Yisheng Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jilin Jian Yisheng Pharmaceutical Co Ltd is ¥6.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jilin Jian Yisheng Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jilin Jian Yisheng Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.80. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jilin Jian Yisheng Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.5%0.030.5%0.040.6%0.030.5%0.030.4%
Usd Book Value Change Per Share0.020.3%0.020.3%0.030.4%0.030.4%0.030.4%
Usd Dividend Per Share0.010.1%0.010.1%0.010.1%0.010.2%0.010.2%
Usd Total Gains Per Share0.030.4%0.030.4%0.040.5%0.040.6%0.040.6%
Usd Price Per Share1.12-1.12-1.25-1.00-1.55-
Price to Earnings Ratio32.26-32.26-31.16-29.45-115.09-
Price-to-Total Gains Ratio35.79-35.79-33.48-25.25-44.16-
Price to Book Ratio1.19-1.19-1.36-1.13-2.00-
Price-to-Total Gains Ratio35.79-35.79-33.48-25.25-44.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9591
Number of shares1042
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.03
Usd Total Gains Per Share0.030.04
Gains per Quarter (1042 shares)32.5443.25
Gains per Year (1042 shares)130.16173.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1418912051122163
283178250101245336
3124267380152367509
4165356510202490682
5206444640253612855
62485337703037351028
72896229003548571201
833071110304049801374
9371800116045511021547
10413889129050512251720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%14.01.00.093.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%

Fundamentals of Jilin Jian Yisheng Pharmaceutical Co Ltd

About Jilin Jian Yisheng Pharmaceutical Co Ltd

Jilin Jian Yisheng Pharmaceutical Co., Ltd. manufactures and sells medicine, Chinese herbal medicine, cosmetics, and ginseng products in China. The company offers injections, tablets, granules, hard capsules, mixtures, eye drops, liniments, liquors, syrups, emulsions, and other raw materials. It also exports self-produced products and related technologies; imports raw and auxiliary materials, mechanical equipment, instruments, spare parts, and related technologies; and provides ordinary freight services. In addition, the company engages in the supplement business; packaging printing; development, processing, and sales of bee products; planting of Chinese herbal medicines; leasing of house, machinery, and equipment; sales of agricultural and sideline products; wholesale and retail of Chinese herbal, proprietary Chinese, decoction pieces of traditional Chinese, and western medicine; retail of medicines; and road transportation of dangerous goods. Further, the company manufactures and sells organic fertilizer and health supplies; health, prepackaged, and bulk food; and sells paper cutting products. Jilin Jian Yisheng Pharmaceutical Co., Ltd. was founded in 1997 and is based in Ji'an, China.

Fundamental data was last updated by Penke on 2024-04-14 17:49:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Jilin Jian Yisheng Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jilin Jian Yisheng Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jilin Jian Yisheng Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 10.0% means that ¥0.10 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 10.0%. The company is making a huge profit. +2
  • The TTM is 10.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.0%TTM10.0%0.0%
TTM10.0%YOY10.9%-0.9%
TTM10.0%5Y9.0%+1.0%
5Y9.0%10Y7.9%+1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.0%-200.1%+210.1%
TTM10.0%-216.8%+226.8%
YOY10.9%-288.3%+299.2%
5Y9.0%-449.1%+458.1%
10Y7.9%-605.5%+613.4%
1.1.2. Return on Assets

Shows how efficient Jilin Jian Yisheng Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jilin Jian Yisheng Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • 2.8% Return on Assets means that Jilin Jian Yisheng Pharmaceutical Co Ltd generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 2.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.8%TTM2.8%0.0%
TTM2.8%YOY3.4%-0.6%
TTM2.8%5Y3.0%-0.2%
5Y3.0%10Y2.6%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8%-13.3%+16.1%
TTM2.8%-12.8%+15.6%
YOY3.4%-11.7%+15.1%
5Y3.0%-13.9%+16.9%
10Y2.6%-15.7%+18.3%
1.1.3. Return on Equity

Shows how efficient Jilin Jian Yisheng Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jilin Jian Yisheng Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • 3.9% Return on Equity means Jilin Jian Yisheng Pharmaceutical Co Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 3.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.9%0.0%
TTM3.9%YOY4.6%-0.8%
TTM3.9%5Y4.0%-0.2%
5Y4.0%10Y3.6%+0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9%-16.9%+20.8%
TTM3.9%-16.1%+20.0%
YOY4.6%-15.1%+19.7%
5Y4.0%-19.3%+23.3%
10Y3.6%-20.2%+23.8%

1.2. Operating Efficiency of Jilin Jian Yisheng Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jilin Jian Yisheng Pharmaceutical Co Ltd is operating .

  • Measures how much profit Jilin Jian Yisheng Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jilin Jian Yisheng Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 10.7% means the company generated ¥0.11  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 10.7%. The company is operating less efficient.
  • The TTM is 10.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ10.7%TTM10.7%0.0%
TTM10.7%YOY13.0%-2.3%
TTM10.7%5Y11.4%-0.7%
5Y11.4%10Y8.3%+3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.7%-296.2%+306.9%
TTM10.7%-232.5%+243.2%
YOY13.0%-298.2%+311.2%
5Y11.4%-492.1%+503.5%
10Y8.3%-632.4%+640.7%
1.2.2. Operating Ratio

Measures how efficient Jilin Jian Yisheng Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.13 means that the operating costs are ¥1.13 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 1.131. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.131. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.131TTM1.1310.000
TTM1.131YOY1.100+0.031
TTM1.1315Y1.102+0.029
5Y1.10210Y0.957+0.145
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1313.231-2.100
TTM1.1313.310-2.179
YOY1.1003.890-2.790
5Y1.1025.739-4.637
10Y0.9577.876-6.919

1.3. Liquidity of Jilin Jian Yisheng Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jilin Jian Yisheng Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.91 means the company has ¥3.91 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 3.915. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.915. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.915TTM3.9150.000
TTM3.915YOY4.163-0.248
TTM3.9155Y4.134-0.219
5Y4.13410Y2.871+1.264
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9153.890+0.025
TTM3.9154.173-0.258
YOY4.1635.344-1.181
5Y4.1346.126-1.992
10Y2.8716.448-3.577
1.3.2. Quick Ratio

Measures if Jilin Jian Yisheng Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jilin Jian Yisheng Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.42 means the company can pay off ¥0.42 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 0.424. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.424. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.424TTM0.4240.000
TTM0.424YOY0.683-0.259
TTM0.4245Y0.526-0.102
5Y0.52610Y0.601-0.075
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4243.514-3.090
TTM0.4243.998-3.574
YOY0.6835.380-4.697
5Y0.5266.105-5.579
10Y0.6016.404-5.803

1.4. Solvency of Jilin Jian Yisheng Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jilin Jian Yisheng Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jilin Jian Yisheng Pharmaceutical Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.24 means that Jilin Jian Yisheng Pharmaceutical Co Ltd assets are financed with 24.2% credit (debt) and the remaining percentage (100% - 24.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 0.242. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.242. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.242TTM0.2420.000
TTM0.242YOY0.233+0.009
TTM0.2425Y0.224+0.018
5Y0.22410Y0.248-0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2420.339-0.097
TTM0.2420.336-0.094
YOY0.2330.271-0.038
5Y0.2240.366-0.142
10Y0.2480.389-0.141
1.4.2. Debt to Equity Ratio

Measures if Jilin Jian Yisheng Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jilin Jian Yisheng Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 33.3% means that company has ¥0.33 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The MRQ is 0.333. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.333. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.333TTM0.3330.000
TTM0.333YOY0.320+0.013
TTM0.3335Y0.306+0.027
5Y0.30610Y0.352-0.046
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3330.388-0.055
TTM0.3330.402-0.069
YOY0.3200.335-0.015
5Y0.3060.426-0.120
10Y0.3520.461-0.109

2. Market Valuation of Jilin Jian Yisheng Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jilin Jian Yisheng Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jilin Jian Yisheng Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 32.26 means the investor is paying ¥32.26 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The EOD is 27.680. Based on the earnings, the company is overpriced. -1
  • The MRQ is 32.260. Based on the earnings, the company is overpriced. -1
  • The TTM is 32.260. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD27.680MRQ32.260-4.580
MRQ32.260TTM32.2600.000
TTM32.260YOY31.158+1.102
TTM32.2605Y29.453+2.807
5Y29.45310Y115.086-85.633
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD27.680-2.264+29.944
MRQ32.260-2.629+34.889
TTM32.260-2.680+34.940
YOY31.158-4.145+35.303
5Y29.453-6.257+35.710
10Y115.086-6.254+121.340
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The EOD is 22.012. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 25.655. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 25.655. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD22.012MRQ25.655-3.642
MRQ25.655TTM25.6550.000
TTM25.655YOY27.693-2.038
TTM25.6555Y20.518+5.137
5Y20.51810Y4.650+15.868
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD22.012-2.973+24.985
MRQ25.655-3.333+28.988
TTM25.655-3.553+29.208
YOY27.693-5.605+33.298
5Y20.518-8.376+28.894
10Y4.650-8.865+13.515
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jilin Jian Yisheng Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.19 means the investor is paying ¥1.19 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Jilin Jian Yisheng Pharmaceutical Co Ltd:

  • The EOD is 1.023. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.192. Based on the equity, the company is underpriced. +1
  • The TTM is 1.192. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.023MRQ1.192-0.169
MRQ1.192TTM1.1920.000
TTM1.192YOY1.361-0.169
TTM1.1925Y1.125+0.067
5Y1.12510Y2.002-0.876
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0231.896-0.873
MRQ1.1922.115-0.923
TTM1.1922.093-0.901
YOY1.3612.884-1.523
5Y1.1253.542-2.417
10Y2.0023.916-1.914
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jilin Jian Yisheng Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1550.1550%0.200-23%0.213-27%0.199-23%
Book Value Per Share--6.7976.7970%6.642+2%6.408+6%5.884+16%
Current Ratio--3.9153.9150%4.163-6%4.134-5%2.871+36%
Debt To Asset Ratio--0.2420.2420%0.233+4%0.224+8%0.248-2%
Debt To Equity Ratio--0.3330.3330%0.320+4%0.306+9%0.352-5%
Dividend Per Share--0.0720.0720%0.070+2%0.088-18%0.090-20%
Eps--0.2510.2510%0.290-13%0.245+3%0.203+24%
Free Cash Flow Per Share--0.3160.3160%0.326-3%0.376-16%0.118+168%
Free Cash Flow To Equity Per Share--0.2430.2430%0.099+146%0.190+28%0.001+17688%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.586--------
Intrinsic Value_10Y_min---2.287--------
Intrinsic Value_1Y_max--0.374--------
Intrinsic Value_1Y_min--0.031--------
Intrinsic Value_3Y_max--1.112--------
Intrinsic Value_3Y_min---0.133--------
Intrinsic Value_5Y_max--1.836--------
Intrinsic Value_5Y_min---0.540--------
Market Cap2300116400.000-17%2680711200.0002680711200.0000%2991806080.000-10%2396754384.000+12%3713281440.000-28%
Net Profit Margin--0.1000.1000%0.109-8%0.090+11%0.079+26%
Operating Margin--0.1070.1070%0.130-18%0.114-6%0.083+29%
Operating Ratio--1.1311.1310%1.100+3%1.102+3%0.957+18%
Pb Ratio1.023-17%1.1921.1920%1.361-12%1.125+6%2.002-40%
Pe Ratio27.680-17%32.26032.2600%31.158+4%29.453+10%115.086-72%
Price Per Share6.950-17%8.1008.1000%9.040-10%7.242+12%11.220-28%
Price To Free Cash Flow Ratio22.012-17%25.65525.6550%27.693-7%20.518+25%4.650+452%
Price To Total Gains Ratio30.713-17%35.79535.7950%33.476+7%25.248+42%44.164-19%
Quick Ratio--0.4240.4240%0.683-38%0.526-19%0.601-29%
Return On Assets--0.0280.0280%0.034-16%0.030-5%0.026+6%
Return On Equity--0.0390.0390%0.046-16%0.040-4%0.036+8%
Total Gains Per Share--0.2260.2260%0.270-16%0.301-25%0.290-22%
Usd Book Value--310421071.641310421071.6410%303363254.005+2%292653978.761+6%268749322.324+16%
Usd Book Value Change Per Share--0.0210.0210%0.028-23%0.029-27%0.028-23%
Usd Book Value Per Share--0.9380.9380%0.917+2%0.884+6%0.812+16%
Usd Dividend Per Share--0.0100.0100%0.010+2%0.012-18%0.012-20%
Usd Eps--0.0350.0350%0.040-13%0.034+3%0.028+24%
Usd Free Cash Flow--14419814.52214419814.5220%14908893.520-3%17191440.692-16%4299655.870+235%
Usd Free Cash Flow Per Share--0.0440.0440%0.045-3%0.052-16%0.016+168%
Usd Free Cash Flow To Equity Per Share--0.0340.0340%0.014+146%0.026+28%0.000+17688%
Usd Market Cap317416063.200-17%369938145.600369938145.6000%412869239.040-10%330752104.992+12%512432838.720-28%
Usd Price Per Share0.959-17%1.1181.1180%1.248-10%0.999+12%1.548-28%
Usd Profit--11467385.20911467385.2090%13250808.286-13%11174010.386+3%9284073.106+24%
Usd Revenue--114545702.702114545702.7020%121154276.781-5%125259769.829-9%120917070.788-5%
Usd Total Gains Per Share--0.0310.0310%0.037-16%0.042-25%0.040-22%
 EOD+4 -4MRQTTM+0 -0YOY+11 -245Y+13 -2210Y+21 -14

3.2. Fundamental Score

Let's check the fundamental score of Jilin Jian Yisheng Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.680
Price to Book Ratio (EOD)Between0-11.023
Net Profit Margin (MRQ)Greater than00.100
Operating Margin (MRQ)Greater than00.107
Quick Ratio (MRQ)Greater than10.424
Current Ratio (MRQ)Greater than13.915
Debt to Asset Ratio (MRQ)Less than10.242
Debt to Equity Ratio (MRQ)Less than10.333
Return on Equity (MRQ)Greater than0.150.039
Return on Assets (MRQ)Greater than0.050.028
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Jilin Jian Yisheng Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.250
Ma 20Greater thanMa 506.978
Ma 50Greater thanMa 1006.796
Ma 100Greater thanMa 2007.755
OpenGreater thanClose6.850
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,966,607
Total Liabilities717,179
Total Stockholder Equity2,154,978
 As reported
Total Liabilities 717,179
Total Stockholder Equity+ 2,154,978
Total Assets = 2,966,607

Assets

Total Assets2,966,607
Total Current Assets2,302,613
Long-term Assets663,994
Total Current Assets
Cash And Cash Equivalents 343,264
Short-term Investments 59,843
Net Receivables 189,685
Inventory 1,603,101
Other Current Assets 10,171
Total Current Assets  (as reported)2,302,613
Total Current Assets  (calculated)2,206,065
+/- 96,548
Long-term Assets
Property Plant Equipment 526,110
Goodwill 1,906
Intangible Assets 117,025
Other Assets 18,954
Long-term Assets  (as reported)663,994
Long-term Assets  (calculated)663,994
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities588,165
Long-term Liabilities129,014
Total Stockholder Equity2,154,978
Total Current Liabilities
Short Long Term Debt 430,427
Accounts payable 24,326
Other Current Liabilities 99,442
Total Current Liabilities  (as reported)588,165
Total Current Liabilities  (calculated)554,195
+/- 33,970
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt9,825
Other Liabilities 119,189
Long-term Liabilities  (as reported)129,014
Long-term Liabilities  (calculated)129,014
+/- 0
Total Stockholder Equity
Common Stock330,952
Retained Earnings 989,337
Total Stockholder Equity (as reported)2,154,978
Total Stockholder Equity (calculated)1,320,289
+/- 834,689
Other
Capital Stock330,952
Common Stock Shares Outstanding 330,952
Net Debt 87,163
Net Invested Capital 2,585,405
Net Tangible Assets 2,036,047
Net Working Capital 1,714,448
Property Plant and Equipment Gross 526,110



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
347,322
427,665
515,059
1,578,630
1,662,173
1,890,655
2,490,347
2,633,726
2,670,721
2,653,486
2,553,101
2,496,514
2,796,099
2,864,367
2,966,607
2,966,6072,864,3672,796,0992,496,5142,553,1012,653,4862,670,7212,633,7262,490,3471,890,6551,662,1731,578,630515,059427,665347,322
   > Total Current Assets 
0
0
0
0
0
0
0
2,154,598
2,156,326
2,117,335
2,014,563
1,983,160
2,223,356
2,221,793
2,302,613
2,302,6132,221,7932,223,3561,983,1602,014,5632,117,3352,156,3262,154,5980000000
       Cash And Cash Equivalents 
23,327
47,135
46,181
883,867
850,610
398,048
312,125
161,802
79,889
80,586
38,843
63,015
286,997
219,695
343,264
343,264219,695286,99763,01538,84380,58679,889161,802312,125398,048850,610883,86746,18147,13523,327
       Short-term Investments 
0
0
0
0
0
0
82,000
33,000
0
4,000
0
0
0
70,163
59,843
59,84370,1630004,000033,00082,000000000
       Net Receivables 
134,994
131,977
161,100
326,647
304,373
322,092
291,251
268,695
293,060
265,503
256,751
273,780
205,230
294,451
189,685
189,685294,451205,230273,780256,751265,503293,060268,695291,251322,092304,373326,647161,100131,977134,994
       Other Current Assets 
8,582
13,162
19,335
4,851
15,675
343,715
197,480
242,447
161,596
101,013
39,572
12,655
10,012
10,529
10,171
10,17110,52910,01212,65539,572101,013161,596242,447197,480343,71515,6754,85119,33513,1628,582
   > Long-term Assets 
0
0
0
0
0
0
0
0
514,394
536,151
538,539
513,353
572,743
642,574
663,994
663,994642,574572,743513,353538,539536,151514,39400000000
       Property Plant Equipment 
100,191
160,130
195,322
221,515
246,254
295,080
295,954
398,360
438,359
458,121
460,602
430,526
423,296
501,486
526,110
526,110501,486423,296430,526460,602458,121438,359398,360295,954295,080246,254221,515195,322160,130100,191
       Goodwill 
0
0
0
0
0
0
1,906
1,906
1,906
1,906
1,906
1,906
1,906
1,906
1,906
1,9061,9061,9061,9061,9061,9061,9061,9061,906000000
       Intangible Assets 
6,823
9,223
1,614
1,538
1,402
888
18,333
60,139
58,521
57,286
55,334
54,738
123,412
119,957
117,025
117,025119,957123,41254,73855,33457,28658,52160,13918,3338881,4021,5381,6149,2236,823
       Long-term Assets Other 
0
0
0
0
0
0
0
0
2,544
3,163
5,069
7,550
2,165
1,038
1,679
1,6791,0382,1657,5505,0693,1632,54400000000
> Total Liabilities 
127,434
146,675
155,661
64,517
72,814
213,794
739,236
888,647
869,671
756,402
587,494
438,662
663,865
666,082
717,179
717,179666,082663,865438,662587,494756,402869,671888,647739,236213,79472,81464,517155,661146,675127,434
   > Total Current Liabilities 
116,033
131,043
138,716
46,762
55,462
181,333
703,145
857,311
837,651
718,447
542,216
396,009
574,522
533,748
588,165
588,165533,748574,522396,009542,216718,447837,651857,311703,145181,33355,46246,762138,716131,043116,033
       Short-term Debt 
0
0
0
0
0
0
0
380
710,000
540,000
430,000
280,000
0
0
0
000280,000430,000540,000710,0003800000000
       Short Long Term Debt 
0
0
0
0
0
0
0
380
710,000
540,000
430,000
280,000
405,402
397,863
430,427
430,427397,863405,402280,000430,000540,000710,0003800000000
       Accounts payable 
6,585
10,020
7,340
12,119
18,093
19,649
134,598
24,143
19,989
25,603
21,436
25,572
24,801
19,813
24,326
24,32619,81324,80125,57221,43625,60319,98924,143134,59819,64918,09312,1197,34010,0206,585
       Other Current Liabilities 
38,448
97,273
91,376
33,513
36,239
61,304
88,167
39,807
51,725
68,192
42,646
59,884
113,737
62,107
99,442
99,44262,107113,73759,88442,64668,19251,72539,80788,16761,30436,23933,51391,37697,27338,448
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
32,020
37,955
45,278
42,653
89,342
132,334
129,014
129,014132,33489,34242,65345,27837,95532,02000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
-380
-710,000
-540,000
-430,000
-280,000
7,453
11,463
9,825
9,82511,4637,453-280,000-430,000-540,000-710,000-3800000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
1,230
850
10,470
12,550
0
0
0
00012,55010,4708501,23000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
1,228
2,101
1,329
748
2,475
4,096
2,989
3,073
3,0732,9894,0962,4757481,3292,1011,2280000000
> Total Stockholder Equity
219,149
280,278
358,725
1,494,267
1,568,830
1,656,149
1,730,494
1,724,739
1,740,875
1,802,913
1,855,607
1,932,205
1,995,718
2,081,810
2,154,978
2,154,9782,081,8101,995,7181,932,2051,855,6071,802,9131,740,8751,724,7391,730,4941,656,1491,568,8301,494,267358,725280,278219,149
   Common Stock
61,272
61,272
82,717
110,317
220,634
220,634
330,952
330,952
330,952
330,952
330,952
330,952
330,952
330,952
330,952
330,952330,952330,952330,952330,952330,952330,952330,952330,952220,634220,634110,31782,71761,27261,272
   Retained Earnings 
87,836
142,846
190,897
278,045
343,268
420,463
569,806
564,170
577,364
637,434
689,966
766,564
830,077
916,169
989,337
989,337916,169830,077766,564689,966637,434577,364564,170569,806420,463343,268278,045190,897142,84687,836
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue858,257
Cost of Revenue-234,384
Gross Profit623,873623,873
 
Operating Income (+$)
Gross Profit623,873
Operating Expense-766,279
Operating Income91,978-142,406
 
Operating Expense (+$)
Research Development18,647
Selling General Administrative451,306
Selling And Marketing Expenses-
Operating Expense766,279469,953
 
Net Interest Income (+$)
Interest Income3,464
Interest Expense-13,878
Other Finance Cost-9,378
Net Interest Income-1,037
 
Pretax Income (+$)
Operating Income91,978
Net Interest Income-1,037
Other Non-Operating Income Expenses-
Income Before Tax (EBT)94,74091,978
EBIT - interestExpense = -13,878
81,233
95,111
Interest Expense13,878
Earnings Before Interest and Taxes (EBIT)-108,618
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax94,740
Tax Provision-12,108
Net Income From Continuing Ops82,63182,631
Net Income81,233
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,037
 

Technical Analysis of Jilin Jian Yisheng Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jilin Jian Yisheng Pharmaceutical Co Ltd. The general trend of Jilin Jian Yisheng Pharmaceutical Co Ltd is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jilin Jian Yisheng Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jilin Jian Yisheng Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.42 < 7.5146 < 7.75.

The bearish price targets are: 6.08 > 5.2.

Tweet this
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current macd is -0.07226036.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jilin Jian Yisheng Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jilin Jian Yisheng Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jilin Jian Yisheng Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current adx is 19.56.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Jilin Jian Yisheng Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current sar is 6.127916.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current rsi is 50.25. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jilin Jian Yisheng Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current cci is -16.48931071.

Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current cmo is 3.20702846.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current willr is -34.58646617.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jilin Jian Yisheng Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Williams %R ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jilin Jian Yisheng Pharmaceutical Co Ltd.

Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current atr is 0.32506689.

Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current obv is 154,648,780.

Jilin Jian Yisheng Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jilin Jian Yisheng Pharmaceutical Co Ltd. The current mfi is 29.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartJilin Jian Yisheng Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jilin Jian Yisheng Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Jilin Jian Yisheng Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jilin Jian Yisheng Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.250
Ma 20Greater thanMa 506.978
Ma 50Greater thanMa 1006.796
Ma 100Greater thanMa 2007.755
OpenGreater thanClose6.850
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jilin Jian Yisheng Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jilin Jian Yisheng Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jilin Jian Yisheng Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jilin Jian Yisheng Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jilin Jian Yisheng Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jilin Jian Yisheng Pharmaceutical Co Ltd.

Receive notifications about Jilin Jian Yisheng Pharmaceutical Co Ltd in your mailbox!